SEEL logo

Seelos Therapeutics (SEEL) Cash From Investing

Annual CFI

N/A

December 31, 2023


Summary


Performance

SEEL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSEELcash flowmetrics:

Quarterly CFI

N/A

June 30, 2024


Summary


Performance

SEEL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSEELcash flowmetrics:

TTM CFI

N/A

June 30, 2024


Summary


Performance

SEEL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSEELcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SEEL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

SEEL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Seelos Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Jun 2018
-
$0.00(0.0%)
$459.00 K(-35.3%)
Mar 2018
-
$0.00(-100.0%)
$709.00 K(-94.2%)
Dec 2017
$12.21 M(+4507.2%)
$209.00 K(-16.4%)
$12.21 M(+1.7%)
Sep 2017
-
$250.00 K(0.0%)
$12.00 M(+2.1%)
Jun 2017
-
$250.00 K(-97.8%)
$11.75 M(+0.7%)
Mar 2017
-
$11.50 M(>+9900.0%)
$11.67 M(+4304.2%)
Dec 2016
$265.00 K(-182.3%)
$3000.00(>+9900.0%)
$265.00 K(+81.5%)
Sep 2016
-
$0.00(-100.0%)
$146.00 K(+23.7%)
Jun 2016
-
$168.00 K(+78.7%)
$118.00 K(-287.3%)
Mar 2016
-
$94.00 K(-181.0%)
-$63.00 K(-80.4%)
Dec 2015
-$322.00 K(-322.1%)
-$116.00 K(+314.3%)
-$322.00 K(+12.6%)
Sep 2015
-
-$28.00 K(+115.4%)
-$286.00 K(-12.3%)
Jun 2015
-
-$13.00 K(-92.1%)
-$326.00 K(-214.4%)
Mar 2015
-
-$165.00 K(+106.3%)
$285.00 K(+96.6%)
Dec 2014
$145.00 K(-96.9%)
-$80.00 K(+17.6%)
$145.00 K(-3725.0%)
Sep 2014
-
-$68.00 K(-111.4%)
-$4000.00(-102.9%)
Jun 2014
-
$598.00 K(-296.1%)
$136.00 K(-132.0%)
Mar 2014
-
-$305.00 K(+33.2%)
-$425.00 K(-109.0%)
Dec 2013
$4.71 M(+340.9%)
-$229.00 K(-418.1%)
$4.71 M(+2.5%)
Sep 2013
-
$72.00 K(+94.6%)
$4.60 M(-26.0%)
Jun 2013
-
$37.00 K(-99.2%)
$6.21 M(+0.6%)
Mar 2013
-
$4.83 M(-1512.0%)
$6.18 M(+478.4%)
Dec 2012
$1.07 M(+210.5%)
-$342.00 K(-120.3%)
$1.07 M(-45.3%)
Sep 2012
-
$1.69 M(>+9900.0%)
$1.95 M(+704.5%)
Jun 2012
-
$2000.00(-100.7%)
$242.70 K(+237.6%)
Mar 2012
-
-$280.00 K(-151.6%)
$71.90 K(-79.1%)
Dec 2011
$344.00 K(-178.9%)
$542.50 K(-2588.5%)
$344.00 K(-218.0%)
Sep 2011
-
-$21.80 K(-87.1%)
-$291.60 K(-202.0%)
Jun 2011
-
-$168.80 K(+2036.7%)
$286.00 K(-178.9%)
Mar 2011
-
-$7900.00(-91.5%)
-$362.50 K(-16.9%)
Dec 2010
-$436.00 K(-226.6%)
-$93.10 K(-116.8%)
-$436.00 K(+26.2%)
Sep 2010
-
$555.80 K(-168.0%)
-$345.50 K(-61.7%)
Jun 2010
-
-$817.30 K(+904.1%)
-$901.30 K(-1123.0%)
Mar 2010
-
-$81.40 K(+3030.8%)
$88.10 K(-74.4%)
Dec 2009
$344.50 K(-56.7%)
-$2600.00(<-9900.0%)
$344.50 K(-18.4%)
Sep 2009
-
$0.00(-100.0%)
$422.10 K(+2.7%)
Jun 2009
-
$172.10 K(-1.7%)
$410.90 K(+74.8%)
Mar 2009
-
$175.00 K(+133.3%)
$235.10 K(-70.5%)
DateAnnualQuarterlyTTM
Dec 2008
$796.00 K(+433.9%)
$75.00 K(-769.6%)
$796.10 K(-16.9%)
Sep 2008
-
-$11.20 K(+202.7%)
$957.70 K(-60.6%)
Jun 2008
-
-$3700.00(-100.5%)
$2.43 M(+1.9%)
Mar 2008
-
$736.00 K(+211.1%)
$2.39 M(+1499.7%)
Dec 2007
$149.10 K(-137.5%)
$236.60 K(-83.8%)
$149.10 K(-83.5%)
Sep 2007
-
$1.46 M(-3070.9%)
$906.00 K(-294.2%)
Jun 2007
-
-$49.20 K(-96.7%)
-$466.50 K(-182.3%)
Mar 2007
-
-$1.50 M(-251.0%)
$566.70 K(-242.5%)
Dec 2006
-$397.80 K(-155.0%)
$993.50 K(+1013.8%)
-$397.80 K(-51.9%)
Sep 2006
-
$89.20 K(-90.9%)
-$826.50 K(+190.1%)
Jun 2006
-
$984.00 K(-139.9%)
-$284.90 K(-47.9%)
Mar 2006
-
-$2.46 M(-536.3%)
-$547.20 K(-175.6%)
Dec 2005
$723.30 K(-173.4%)
$564.80 K(-10.5%)
$723.40 K(+90.3%)
Sep 2005
-
$630.80 K(-12.6%)
$380.20 K(-126.5%)
Jun 2005
-
$721.70 K(-160.4%)
-$1.44 M(-34.3%)
Mar 2005
-
-$1.19 M(-638.8%)
-$2.19 M(+122.1%)
Dec 2004
-$985.00 K(+386.2%)
$221.60 K(-118.7%)
-$985.00 K(+289.3%)
Sep 2004
-
-$1.19 M(+3920.3%)
-$253.00 K(-59.5%)
Jun 2004
-
-$29.50 K(-431.5%)
-$624.80 K(-17.4%)
Mar 2004
-
$8900.00(-99.1%)
-$756.40 K(+273.3%)
Dec 2003
-$202.60 K(-197.9%)
$953.60 K(-161.2%)
-$202.60 K(-88.4%)
Sep 2003
-
-$1.56 M(+867.0%)
-$1.74 M(+173.8%)
Jun 2003
-
-$161.10 K(-128.6%)
-$637.30 K(-133.3%)
Mar 2003
-
$562.70 K(-195.6%)
$1.91 M(+825.4%)
Dec 2002
$206.90 K(-113.2%)
-$588.60 K(+30.7%)
$206.90 K(-91.3%)
Sep 2002
-
-$450.30 K(-118.8%)
$2.38 M(-22.7%)
Jun 2002
-
$2.39 M(-308.8%)
$3.08 M(-659.5%)
Mar 2002
-
-$1.15 M(-172.1%)
-$550.80 K(-65.0%)
Dec 2001
-$1.57 M(-86.3%)
$1.59 M(+540.4%)
-$1.57 M(-84.4%)
Sep 2001
-
$248.00 K(-120.0%)
-$10.07 M(-12.4%)
Jun 2001
-
-$1.24 M(-42.7%)
-$11.49 M(-1.1%)
Mar 2001
-
-$2.17 M(-68.7%)
-$11.63 M(+1.0%)
Dec 2000
-$11.52 M(<-9900.0%)
-$6.91 M(+489.6%)
-$11.52 M(+150.2%)
Sep 2000
-
-$1.17 M(-14.7%)
-$4.60 M(+34.2%)
Jun 2000
-
-$1.37 M(-33.2%)
-$3.43 M(+66.8%)
Mar 2000
-
-$2.06 M
-$2.06 M
Dec 1999
$100.00 K(-91.8%)
-
-
Dec 1998
$1.22 M(-171.1%)
-
-
Dec 1997
-$1.72 M
-
-

FAQ

  • What is the all time high annual CFI for Seelos Therapeutics?
  • What is the all time high quarterly CFI for Seelos Therapeutics?
  • What is the all time high TTM CFI for Seelos Therapeutics?

What is the all time high annual CFI for Seelos Therapeutics?

Seelos Therapeutics all-time high annual cash flow from investing activities is $12.21 M

What is the all time high quarterly CFI for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly cash flow from investing activities is $11.50 M

What is the all time high TTM CFI for Seelos Therapeutics?

Seelos Therapeutics all-time high TTM cash flow from investing activities is $12.21 M